Wuppertal, Germany

Susanne Nikolic

This inventor holds 2 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 2003-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susanne Nikolic. Retrieved from https://idiyas.com/inventor/susanne-nikolic-y5txbm5j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Susanne Nikolic: Innovator in Pharmaceutical Chemistry

Introduction

Susanne Nikolic is a prominent inventor based in Wuppertal, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. Her work focuses on creating effective treatments for diseases such as coronary heart disease.

Latest Patents

Nikolic holds 2 patents related to propionic acid derivatives. Her latest inventions involve potent PPAR-alpha-activating compounds that are useful in treating coronary heart disease. These inventions also include methods for the preparation of these compounds, showcasing her innovative approach to pharmaceutical development.

Career Highlights

Throughout her career, Susanne Nikolic has been associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. Her work at Bayer has allowed her to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Nikolic has worked alongside notable colleagues such as Klaus Urbahns and Michael Woltering. These collaborations have further enhanced her research and have led to advancements in the treatment of cardiovascular diseases.

Conclusion

Susanne Nikolic's contributions to pharmaceutical chemistry and her innovative patents highlight her role as a key inventor in the industry. Her work continues to impact the development of effective treatments for serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…